Pharmacokinetics of progesterone a few other countries under the brand name Progestasert. It was marketed between 1976 and 2001. The IUD was never widely used due to a relatively high contraceptive failure rate of 2.9% and the requirement of annual replacement. It contained 38 mg progesterone and released 65 μg progesterone into the uterus per day (adding up to about 35 mg after one year). For comparison, a woman's body produces on average about 25 mg progesterone per day during the luteal phase. While effective as a form of contraception and for decreasing menstrual bleeding and discomfort, long-lived IUDs can fundamentally only deliver
Pharmacokinetics of progesterone half-life of progesterone in the circulation is very short at a range of about 3 to 90 minutes. Previous studies using RIA have reported an overestimated half-life of oral progesterone of about 16 to 18 hours. A subsequent, reliable study using high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) reported a half-life of oral progesterone of about 4.6 to 5.2 hours when it was taken with food. Due to the short half-life and duration of action of oral progesterone, it is often taken in divided doses of two or three times per day. Because of studies that used RIA, it was incorrectly